[go: up one dir, main page]

WO2008038140A3 - Vecteur expansible à base de polypropylène glycol et compositions pharmaceutiques associées - Google Patents

Vecteur expansible à base de polypropylène glycol et compositions pharmaceutiques associées Download PDF

Info

Publication number
WO2008038140A3
WO2008038140A3 PCT/IB2007/003463 IB2007003463W WO2008038140A3 WO 2008038140 A3 WO2008038140 A3 WO 2008038140A3 IB 2007003463 W IB2007003463 W IB 2007003463W WO 2008038140 A3 WO2008038140 A3 WO 2008038140A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypropylene glycol
alkyl ether
pharmaceutical compositions
glycol alkyl
foamable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2007/003463
Other languages
English (en)
Other versions
WO2008038140A2 (fr
Inventor
Doron Freidman
Dov Tamarkin
Naomi Feiman
David Schuz
Tal Berman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Foamix Ltd
Original Assignee
Foamix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/481,596 external-priority patent/US8119150B2/en
Priority claimed from US11/488,989 external-priority patent/US10117812B2/en
Priority claimed from US11/717,897 external-priority patent/US8119109B2/en
Application filed by Foamix Ltd filed Critical Foamix Ltd
Priority to EP07848880A priority Critical patent/EP2029106A2/fr
Publication of WO2008038140A2 publication Critical patent/WO2008038140A2/fr
Publication of WO2008038140A3 publication Critical patent/WO2008038140A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N53/00—Biocides, pest repellants or attractants, or plant growth regulators containing cyclopropane carboxylic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/16—Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne un support pharmaceutique expansible comprenant alkyle éther de polypropylène glycol (PPG), une eau agent tensio-actif et un propulseur de gaz d'hydrocarbure liquéfié; ainsi que des compositions pharmaceutiques de ceux-ci. L'invention concerne en outre un support pharmaceutique expansible comprenant alkyle éther de prolypropylène glycol (PPG), un agent tensio-actif, et un propulseur de gaz d'hydrocarbure liquéfié; ainsi que des compositions pharmaceutiques de ceux-ci.
PCT/IB2007/003463 2006-06-07 2007-06-07 Vecteur expansible à base de polypropylène glycol et compositions pharmaceutiques associées Ceased WO2008038140A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07848880A EP2029106A2 (fr) 2006-06-07 2007-06-07 Vecteur expansible à base de polypropylène glycol et compositions pharmaceutiques associées

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US81162706P 2006-06-07 2006-06-07
US60/811,627 2006-06-07
US11/481,596 US8119150B2 (en) 2002-10-25 2006-07-06 Non-flammable insecticide composition and uses thereof
US11/482,596 2006-07-07
US11/488,989 US10117812B2 (en) 2002-10-25 2006-07-19 Foamable composition combining a polar solvent and a hydrophobic carrier
US11/488,989 2006-07-19
US11/717,897 2007-03-13
US11/717,897 US8119109B2 (en) 2002-10-25 2007-03-13 Foamable compositions, kits and methods for hyperhidrosis

Publications (2)

Publication Number Publication Date
WO2008038140A2 WO2008038140A2 (fr) 2008-04-03
WO2008038140A3 true WO2008038140A3 (fr) 2008-09-04

Family

ID=39230597

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/003463 Ceased WO2008038140A2 (fr) 2006-06-07 2007-06-07 Vecteur expansible à base de polypropylène glycol et compositions pharmaceutiques associées

Country Status (2)

Country Link
EP (1) EP2029106A2 (fr)
WO (1) WO2008038140A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8946276B2 (en) 2011-06-28 2015-02-03 Watson Laboratories, Inc. High dosage mucoadhesive metronidazole aqueous-based gel formulations and their use to treat bacterial vaginosis

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
ES2326387T3 (es) 2005-03-24 2009-10-08 Nolabs Ab Tratamiento cosmetico con oxido nitrico, dispositivo para llevar a cabo dicho tratamiento y procedimiento de fabricacion del mismo.
EP1917072B1 (fr) 2005-06-01 2013-02-27 Stiefel Research Australia Pty Ltd Preparation vitaminee
SI2344198T1 (sl) * 2008-09-27 2021-01-29 Jina Pharmaceuticals Inc. Farmacevtski pripravki na lipidni osnovi za topično uporabo
BRPI0923534B1 (pt) 2008-12-22 2017-03-28 Johnson & Johnson Consumer Holdings France composição cosmética de emulsão de óleo em água não formadora de espuma e uso da mesma
ATE500817T1 (de) 2008-12-23 2011-03-15 Intendis Gmbh Schäumbare zusammensetzung, die im wesentlichen frei von pharmazeutisch aktiven inhaltsstoffen ist, zur behandlung der menschlichen haut
WO2010123564A1 (fr) * 2009-04-22 2010-10-28 Agency For Science, Technology And Research Émulsions pour une administration transdermique
CA3062005C (fr) 2009-08-21 2022-02-15 Novan, Inc. Gels topiques renfermant de l'oxyde nitrique liberant des macromoleculesde polysiloxanegels leurs utilisations
BR112012003804B1 (pt) 2009-08-21 2019-02-19 Novan, Inc. Curativo para ferimentos, método para formar um curativo para ferimentos, e, kit de curativo para ferimento
EP2544662B1 (fr) 2010-03-10 2020-05-20 Nuvo Pharmaceuticals Inc. Formulation expansible
WO2013006613A1 (fr) 2011-07-05 2013-01-10 Novan, Inc. Procédés de fabrication de compositions topiques et appareil afférent
JP6277124B2 (ja) 2011-07-05 2018-02-07 ノヴァン，インコーポレイテッド 局所用組成物
AU2013232576B2 (en) 2012-03-14 2016-09-01 Ligand Pharmaceuticals Incorporated Nitric oxide releasing pharmaceutical compositions
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
FR3004641B1 (fr) * 2013-04-17 2016-01-15 Oreal Composition cosmetique comprenant un compose d'acide cucurbique et une huile polaire (poly)oxyalkylenee
ES2836132T3 (es) 2013-08-08 2021-06-24 Novan Inc Composiciones tópicas y métodos de uso de las mismas
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
KR102495101B1 (ko) 2014-07-11 2023-02-02 노반, 인크. 국소 항바이러스 조성물 및 그의 사용 방법
WO2016010988A1 (fr) 2014-07-14 2016-01-21 Novan, Inc. Compositions de revêtement pour les ongles libérant de l'oxyde nitrique, des revêtements d'ongles libérant de l'oxyde nitrique, et leurs procédés d'utilisation
CN105813617B (zh) 2014-08-08 2021-05-28 诺万公司 局部用组合物和使用所述组合物的方法
JP6929829B2 (ja) 2015-07-24 2021-09-01 ソレント・セラピューティクス・インコーポレイテッド 薬剤送達装置
WO2017019614A1 (fr) 2015-07-28 2017-02-02 Novan, Inc. Associations et méthodes de traitement et/ou de prévention d'infections fongiques
WO2017023622A1 (fr) * 2015-08-06 2017-02-09 The Dial Corporation Compositions anti-transpiration contenant des agents de masquage, et procédés de production correspondants
DE102015221568A1 (de) 2015-11-04 2017-05-04 Beiersdorf Ag Kosmetischer Schaum aus einer Emulsion enthaltend Glycerin und Alkohol
JP7090549B2 (ja) 2016-03-02 2022-06-24 ノヴァン，インコーポレイテッド 炎症のための治療用組成物およびその治療方法
JP6899845B2 (ja) 2016-04-13 2021-07-07 ノヴァン，インコーポレイテッド 感染症を治療するための組成物、システム、キットおよび方法
JP6875502B2 (ja) * 2016-09-19 2021-05-26 ザ プロクター アンド ギャンブル カンパニーＴｈｅ Ｐｒｏｃｔｅｒ ＆ Ｇａｍｂｌｅ Ｃｏｍｐａｎｙ 発泡性組成物、エアゾール製品、及び皮膚への感覚的な利益を改善するためのそれらの使用方法
CN111655233A (zh) * 2018-01-26 2020-09-11 宝洁公司 用于减轻阴道干燥感的方法和组合物
WO2019147877A1 (fr) * 2018-01-26 2019-08-01 The Procter & Gamble Company Procédés et compositions pour réduire la sensation de sécheresse vaginale
WO2019169221A1 (fr) 2018-03-01 2019-09-06 Novan, Inc. Suppositoires libérant de l'oxyde nitrique et leurs procédés d'utilisation
GB2574022A (en) * 2018-05-22 2019-11-27 Thornton & Ross Ltd A pediculicidal shampoo
GB201813876D0 (en) 2018-08-24 2018-10-10 Antibiotx As Treatment
WO2020089467A1 (fr) 2018-11-02 2020-05-07 UNION therapeutics A/S Régime posologique
CA3118172A1 (fr) 2018-11-02 2020-05-07 UNION therapeutics A/S Salicylanilides halogenes pour le traitement des symptomes de dermatite
DE102018009781A1 (de) * 2018-12-13 2020-06-18 Valeopharm GmbH Verschäumbare wässrige Zubereitungen auf natürlicher Biopolymerbasis mit einsatzflexibler Gas(- vor allem Sauerstoffgas)-Speicherzellen-Verteilung
US11590073B2 (en) 2020-06-09 2023-02-28 The Procter & Gamble Company Methods and compositions for reducing the feeling of vaginal dryness
USD998474S1 (en) 2020-11-25 2023-09-12 The Procter & Gamble Company Aerosol dispenser
US12502339B2 (en) 2021-05-03 2025-12-23 The Procter & Gamble Company Foam compositions
USD1015881S1 (en) 2021-05-03 2024-02-27 The Procter & Gamble Company Aerosol foam dispenser
WO2022235600A1 (fr) 2021-05-03 2022-11-10 The Procter & Gamble Company Distributeur de mousse aérosol

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5429815A (en) * 1994-04-11 1995-07-04 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Stable single-phase self-foaming cleanser
US5783202A (en) * 1995-03-14 1998-07-21 Soltec Research Pty. Ltd. Pediculicidal mousse composition for killing head lice
EP1287813A1 (fr) * 2001-08-28 2003-03-05 Coty Inc. Emulsion déodorante contre la transpiration
US20030053961A1 (en) * 2001-07-13 2003-03-20 Eccard Wayne Ellis Mousse forming compositions comprising quaternary ammonium agents
EP1428521A2 (fr) * 2002-12-13 2004-06-16 Unilever Plc Composition antitranspirante ou déodorante
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
WO2007099396A2 (fr) * 2005-06-07 2007-09-07 Foamix Ltd. Kit et composition antibiotiques et leurs utilisations

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5429815A (en) * 1994-04-11 1995-07-04 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Stable single-phase self-foaming cleanser
US5783202A (en) * 1995-03-14 1998-07-21 Soltec Research Pty. Ltd. Pediculicidal mousse composition for killing head lice
US20030053961A1 (en) * 2001-07-13 2003-03-20 Eccard Wayne Ellis Mousse forming compositions comprising quaternary ammonium agents
EP1287813A1 (fr) * 2001-08-28 2003-03-05 Coty Inc. Emulsion déodorante contre la transpiration
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
EP1428521A2 (fr) * 2002-12-13 2004-06-16 Unilever Plc Composition antitranspirante ou déodorante
WO2007099396A2 (fr) * 2005-06-07 2007-09-07 Foamix Ltd. Kit et composition antibiotiques et leurs utilisations

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8946276B2 (en) 2011-06-28 2015-02-03 Watson Laboratories, Inc. High dosage mucoadhesive metronidazole aqueous-based gel formulations and their use to treat bacterial vaginosis
US9198858B2 (en) 2011-06-28 2015-12-01 Watson Pharmaceuticals, Inc. Methods of treating bacterial vaginosis with aqueous-based metronidazole gel formulations

Also Published As

Publication number Publication date
EP2029106A2 (fr) 2009-03-04
WO2008038140A2 (fr) 2008-04-03

Similar Documents

Publication Publication Date Title
WO2008038140A3 (fr) Vecteur expansible à base de polypropylène glycol et compositions pharmaceutiques associées
IN2014DN07569A (fr)
WO2007053670A3 (fr) Agents gonflants concus pour produire une mousse et comprenant des fluorocarbures insatures
EP2327753A3 (fr) Agents propulseurs d'aérosol comprenant des fluorocarbures insaturés
WO2010040019A3 (fr) Compositions pour mousses résistant à l'abrasion et procédés de fabrication de celles-ci
MXPA05008479A (es) Espuma hidroalcoholica formadora de pelicula.
WO2006023627A8 (fr) Polymorphes de rapamycine et leurs utilisations
IL221579A (en) Foams, pre-blended compositions, and inflating materials containing fluorinated olefins and foam preparation methods
TW200744667A (en) Foamable suspension gel
WO2008012532A3 (fr) Composés chimiques 428
PL1627568T3 (pl) Pieniący się rozpuszczalny proszek kawowy zawierający sprężony gaz
GB0412510D0 (en) Internalized component for fuel tanks
WO2008067028A3 (fr) Mousses à haute teneur en alcool
WO2008089413A3 (fr) Mousse d'urée
PL1791438T3 (pl) Sproszkowana, rozpuszczalna/ rozpraszana w zimnej wodzie, spienialna kompozycja
WO2004004639A3 (fr) Nouvelle formulation stable
WO2006136279A3 (fr) Agent formant du gaz destine a une composition de ciment
IL162412A0 (en) Foamable compositions, processes of preparing sameand uses thereof
WO2009021036A3 (fr) Mousses de polyuréthane souples ignifugées et formulations de mousses de polyuréthane souples
MX2007007550A (es) Composiciones de espuma de poliestireno expandido, retardadoras de la flama.
WO2009154374A3 (fr) Armatures métal-organique poreuses permanentes présentant une structure topologique nbo-net renfermant un groupe azo donneur d’électrons et contenant de gaz comprenant ces armatures
WO2006128622A3 (fr) Compositions d'aerosol deodorantes contenant des huiles et des substances actives qui rafraichissent la peau
WO2010045435A3 (fr) Composition d’acide salicylique
WO2008070354A3 (fr) Benzidimidazole thiophènes substitués en 5 et 6 pour plk
WO2007078679A3 (fr) Synthèse pratique et économique d'ubiquinones

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2007848880

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: RU

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07848880

Country of ref document: EP

Kind code of ref document: A2